Radiofrequency Ablation Combined With S-1 for Pancreatic Cancer With Liver Metastasis

Summary

This study aims to explore the efficacy and safety of radiofrequency ablation combined with S-1 in pancreatic cancer patients with liver metastasis, as well as the correlation of serum microRNA and patients' prognosis. This protocol will be overseen by the Fudan University Institutional Review Board which has Federal Wide Assurance through the U.S. Department of Health \& Human Services (Approved: April 25, 2002).

Timeline

Start

2013-10

Primary completion

2018-12

Completion

—

Drugs

Indications